Pulse Biosciences, Inc. PLSE Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$72.78M-35.8% | -$53.59M-26.9% | -$42.21M+27.9% | -$58.51M+8.1% | ||
| $410K-9.5% | $453K-4.2% | $473K-24.9% | $630K+41.9% | ||
| $21.46M+57.9% | $13.59M+89.2% | $7.18M+38.3% | $5.19M-64.4% | ||
| -$54.12M-48.9% | -$36.34M-10.0% | -$33.04M+29.7% | -$47.01M+13.1% | ||
| $315K+152% | $125K+3.3% | $121K-69.8% | $401K-8.2% | ||
| -$335K-168% | -$125K-3.3% | -$121K+69.8% | -$401K— | ||
| $17.15M-84.5% | $110.41M+574% | $16.39M-79.5% | $79.96M+26.4% | ||
| -$37.3M-151% | $73.67M— | —— | —— | ||
| -$54.44M-49.3% | -$36.47M-10.0% | -$33.16M+30.1% | -$47.41M+13.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Pulse Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.